(NASDAQ: GBIO) Generation Bio Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.8%.
Generation Bio Co's earnings in 2025 is -$72,420,000.On average, 2 Wall Street analysts forecast GBIO's earnings for 2025 to be -$63,617,213, with the lowest GBIO earnings forecast at -$65,267,421, and the highest GBIO earnings forecast at -$61,967,005. On average, 3 Wall Street analysts forecast GBIO's earnings for 2026 to be -$50,988,068, with the lowest GBIO earnings forecast at -$76,987,268, and the highest GBIO earnings forecast at -$9,968,605.
In 2027, GBIO is forecast to generate -$42,097,150 in earnings, with the lowest earnings forecast at -$61,967,005 and the highest earnings forecast at -$22,227,295.